Showing results (361-370 of 408) with videos related to
Sort By:
Pageof 41
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 7, 2023
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetesMing-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, et al.Molecular and Cellular Endocrinology|September 29, 2025
Adenosine A2AR agonist blocks mesenteric lymphatic epithelium, adipose tissue and Treg cells links of metabolic dysfunction-associated steatotic liver disease miceTzu-Hao Li, Hsiao-Yun Yeh, Shang-Wei Lin, et al.Gastroenterology Research and Practice|May 27, 2020
Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-AnalysisTzu-Hao Li, Yu-Lien Tsai, Chien-Fu Hsu, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsMing-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.Journal of the Chinese Medical Association : JCMA|October 1, 2016
Higher platelet counts are associated with metabolic syndrome independent of fatty liver diagnosisKuan-Chieh Fang, Yuan-Lung Cheng, Chien-Wei Su, et al.Biomed Research International|July 20, 2019
Elafibranor Inhibits Chronic Kidney Disease Progression in NASH MiceHung-Cheng Tsai, Fu-Pang Chang, Tzu-Hao Li, et al.Medicine|August 13, 2015
Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis BI-Cheng Lee, Cheuk-Kay Sun, Chien-Wei Su, et al.BMJ Open Gastroenterology|May 7, 2020
SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH miceChih-Wei Liu, Chia-Chang Huang, Chien-Fu Hsu, et al.Clinical and Translational Gastroenterology|November 24, 2025
Microbial Consortia-Immunoglobulin G Glycosylation Combination Scores Identify Severe Hepatic Steatosis and Significant Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseTzu-Hao Li, Chia-Chen Ma, Jhen-Wei Ruan, et al.Clinical Science (London, England : 1979)|July 30, 2020
Obeticholic acid ameliorates hepatorenal syndrome in ascitic cirrhotic rats by down-regulating the renal 8-iso-PGF2α-activated COX-TXA2 pathwayYu-Lien Tsai, Chih-Wei Liu, Chien-Fu Hsu, et al.Pageof 41